We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Atmo Biosciences Stock

Invest in or calculate the value of your shares in Atmo Biosciences or other pre-IPO companies through EquityZen's platform.

Get Started

Atmo Biosciences Stock (ATBI)

Atmo Biosciences is an Australian digital health startup.

About Atmo Biosciences Stock

Founded

2018

Industries

Software, Artificial Intelligence, Data and Analytics

Atmo is a clinical stage digital health business focussed on empowering researchers, clinicians and patients with objective real-time insights into gut health and microbiome function. Atmo addresses the unmet clinical need to monitor microbiome function, allowing better diagnosis and management of personalised therapies for gastrointestinal disorders, resulting in improved gut health and wellness. The company is underpinned by a world-first ingestible gas-sensing capsule + cloud platform, which continuously measures clinically important gaseous biomarkers during transit through the gut and transmits the data wirelessly to the cloud for aggregation and analysis, to determine gut health or dysfunction, resulting in earlier relief of symptoms through personalised therapeutic approaches.

Atmo Biosciences Press Mentions

Stay in the know about the latest news on Atmo Biosciences

Atmo Biosciences Management

Leadership team at Atmo Biosciences

CEO, Co-founder & Executive Director

Malcolm Hebblewhite

Locked Features

Join now and verify your accreditation status to gain access to:

  • Atmo Biosciences current valuation
  • Atmo Biosciences stock price
  • Available deals in Atmo Biosciences and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Atmo Biosciences stock?

Accredited investors can buy pre-IPO stock in companies like Atmo Biosciences through EquityZen funds. These investments are made available by existing Atmo Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Atmo Biosciences stock?

Shareholders can sell their Atmo Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."